(Q31097717)

28 June 2017

1 reference

title

MR spectroscopy in neurodegenerative disease (English)

1 reference

28 June 2017

1 reference

W R Wayne Martin

1

1 reference

28 June 2017

publication date

1 July 2007

1 reference

Molecular Imaging and Biology

28 June 2017

published in

1 reference

28 June 2017

volume

9

1 reference

28 June 2017

issue

4

1 reference

28 June 2017

page(s)

196-203

1 reference

Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11307-007-0087-2

Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-007-0087-2

Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke. A proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-007-0087-2

Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-007-0087-2

Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-007-0087-2

Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-007-0087-2

Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-007-0087-2

Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-007-0087-2

Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-007-0087-2

Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-007-0087-2

1H MR spectroscopy in common dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-007-0087-2

Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-007-0087-2

Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-007-0087-2

Longitudinal changes during aging using proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-007-0087-2

Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-007-0087-2

Magnetic resonance spectroscopy in AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-007-0087-2

Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-007-0087-2

Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-007-0087-2

Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy

21 January 2018

1 reference

12 December 2020

In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease

1 reference

12 December 2020

Phosphorus magnetic resonance spectroscopy in multiple system atrophy and Parkinson's disease

1 reference

12 December 2020

Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients

1 reference

12 December 2020

Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia

1 reference

12 December 2020

In vivo 1H-[13C]-NMR spectroscopy of cerebral metabolism

1 reference

12 December 2020

1 reference

12 December 2020

Nonoxidative glucose consumption during focal physiologic neural activity

1 reference

12 December 2020

A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment.

1 reference

12 December 2020

A prospective, randomized, placebo‐controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results

1 reference

12 December 2020

Proton MR spectroscopic imaging of the striatum in Parkinson's disease

1 reference

12 December 2020

N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction

1 reference

12 December 2020

(1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging.

1 reference

12 December 2020

Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study

1 reference

12 December 2020

Automatic quantitation of localized in vivo 1H spectra with LCModel.

1 reference

12 December 2020

Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease

1 reference

12 December 2020

Mitochondrial involvement in Parkinson's disease: the controversy continues

1 reference

12 December 2020

Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy

1 reference

12 December 2020

N-acetylaspartate as a reservoir for glutamate

1 reference

12 December 2020

Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy

1 reference

12 December 2020

Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease

1 reference

12 December 2020

Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease

1 reference

12 December 2020

Neuronal-glial glucose oxidation and glutamatergic-GABAergic function.

1 reference

12 December 2020

A critical assessment of methods of measuring metabolite concentrations by NMR spectroscopy

1 reference

12 December 2020

Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations.

1 reference

12 December 2020

The role of spectroscopy in parkinsonism

1 reference

12 December 2020

Applications of neural network analyses to in vivo 1H magnetic resonance spectroscopy of Parkinson disease patients

1 reference

12 December 2020

In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease

1 reference

12 December 2020

In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard

1 reference

12 December 2020

Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle

1 reference

12 December 2020

Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy

1 reference

12 December 2020

Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy

1 reference

12 December 2020

Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.

1 reference

12 December 2020

Reduced phospholipid breakdown in Alzheimer's brains: a 31P spectroscopy study.

1 reference

12 December 2020

Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy

1 reference

12 December 2020

Reflections on the application of 13C-MRS to research on brain metabolism

1 reference

12 December 2020

Localized in vivo 13C NMR spectroscopy of the brain

1 reference

12 December 2020

Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes

1 reference

12 December 2020

Quantitative 1H and 31P MRS of PCA extracts of postmortem Alzheimer's disease brain.

1 reference

12 December 2020

Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo

1 reference

12 December 2020

Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration

1 reference

12 December 2020

Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types

1 reference

12 December 2020

Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy

1 reference

12 December 2020

Metabolite-specific NMR spectroscopy in vivo.

1 reference

12 December 2020

What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?

1 reference

12 December 2020

Parkinson's disease and brain mitochondrial dysfunction: a functional phosphorus magnetic resonance spectroscopy study

1 reference

12 December 2020

Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes

1 reference

12 December 2020

Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy

1 reference

12 December 2020

Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker

1 reference

12 December 2020

Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span.

1 reference

12 December 2020

Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study.

1 reference

12 December 2020

Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study

1 reference

12 December 2020

Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile

1 reference

12 December 2020

Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis.

1 reference

12 December 2020

Proton magnetic resonance spectroscopy with dementia

1 reference

12 December 2020

10.1007/S11307-007-0087-2

Identifiers

DOI

1 reference

Dimensions Publication ID

28 June 2017

1015300284

0 references

Fatcat ID

release_5kfggjxperevrlslfamnbzadzy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5kfggjxperevrlslfamnbzadzy

24 November 2022

mapped directly with Wikidata item

1 reference